Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Taylor

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Human Genetics|August 19, 2004
Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2Peter Eck, Hans Christian Erichsen, James G Taylor, et al.
British Journal of Haematology|March 17, 2010
Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertensionSuzana Zorca, Lita Freeman, Mariana Hildesheim, et al.
British Journal of Haematology|April 7, 2009
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathGregory J Kato, Zeneng Wang, Roberto F Machado, et al.
Plos One|May 8, 2008
Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive painJames G Taylor, Vikki G Nolan, Laurel Mendelsohn, et al.
American Journal of Hematology|February 9, 2002
Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell diseaseJames G Taylor, Delia Tang, Charles B Foster, et al.
Circulation. Cardiovascular Genetics|March 4, 2014
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction modelsJacqueline N Milton, Victor R Gordeuk, James G Taylor, et al.
Human Mutation|April 14, 2007
Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populationsGila Idelman, James G Taylor, Ron Tongbai, et al.
Journal of the National Medical Association|June 24, 2017
Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell DiseaseDeepika S Darbari, Ros S Fasano, Caterina P Minniti, et al.
Medical Mycology|August 23, 2005
Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patientsEun Hwa Choi, James G Taylor, Charles B Foster, et al.
American Journal of Nephrology|August 10, 2021
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney DiseaseSergei Nekhai, Xionghao Lin, Simran Soni, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Human Genetics|August 19, 2004
Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2Peter Eck, Hans Christian Erichsen, James G Taylor, et al.
British Journal of Haematology|March 17, 2010
Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertensionSuzana Zorca, Lita Freeman, Mariana Hildesheim, et al.
British Journal of Haematology|April 7, 2009
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathGregory J Kato, Zeneng Wang, Roberto F Machado, et al.
Plos One|May 8, 2008
Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive painJames G Taylor, Vikki G Nolan, Laurel Mendelsohn, et al.
American Journal of Hematology|February 9, 2002
Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell diseaseJames G Taylor, Delia Tang, Charles B Foster, et al.
Circulation. Cardiovascular Genetics|March 4, 2014
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction modelsJacqueline N Milton, Victor R Gordeuk, James G Taylor, et al.
Human Mutation|April 14, 2007
Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populationsGila Idelman, James G Taylor, Ron Tongbai, et al.
Journal of the National Medical Association|June 24, 2017
Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell DiseaseDeepika S Darbari, Ros S Fasano, Caterina P Minniti, et al.
Medical Mycology|August 23, 2005
Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patientsEun Hwa Choi, James G Taylor, Charles B Foster, et al.
American Journal of Nephrology|August 10, 2021
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney DiseaseSergei Nekhai, Xionghao Lin, Simran Soni, et al.
Pageof 6